SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 148 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19,980 | +109.7% | 20,812 | +63.8% | 0.00% | – |
| Q1 2023 | $9,530 | +106.9% | 12,706 | +1.6% | 0.00% | – |
| Q4 2022 | $4,607 | -23.2% | 12,503 | -3.3% | 0.00% | – |
| Q3 2022 | $6,000 | -40.0% | 12,934 | +1.7% | 0.00% | – |
| Q2 2022 | $10,000 | -37.5% | 12,715 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | 0.0% | 12,715 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -42.9% | 12,715 | 0.0% | 0.00% | – |
| Q3 2021 | $28,000 | -41.7% | 12,715 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | +17.1% | 12,715 | 0.0% | 0.00% | – |
| Q1 2021 | $41,000 | -4.7% | 12,715 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | -27.1% | 12,715 | -12.1% | 0.00% | – |
| Q3 2020 | $59,000 | +20.4% | 14,465 | 0.0% | 0.00% | – |
| Q2 2020 | $49,000 | +44.1% | 14,465 | 0.0% | 0.00% | – |
| Q1 2020 | $34,000 | -35.8% | 14,465 | 0.0% | 0.00% | – |
| Q4 2019 | $53,000 | -55.8% | 14,465 | 0.0% | 0.00% | – |
| Q3 2019 | $120,000 | – | 14,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |